Dihydrotestosterone alters cyclooxygenase-2 levels in human coronary artery smooth muscle cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 298, Issue 4, 2010, Pages

  Osterlund, Kristen L ^a,b   Handa, Robert J ^a   Gonzales, Rayna J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Androgen; Inflammation; Interleukin 1 ; Lipopolysaccharide; Vascular smooth muscle

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BICALUTAMIDE; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

ARTICLE; ATTENUATION; CONTROLLED STUDY; CORONARY ARTERY; HUMAN; HUMAN CELL; HYPOTHESIS; INFLAMMATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; CORONARY VESSELS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINES; DIHYDROTESTOSTERONE; DINOPROSTONE; ENDOTHELIUM, VASCULAR; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, ANDROGEN;

EID: 77949842423     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00693.2009     Document Type: Article

References (39)

1. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84: 813-819, 1999.
2. Benten WP, Lieberherr M, Giese G, Wrehlke C, Stamm O, Sekeris CE, Mossmann H, Wunderlich F. Functional testosterone receptors in plasma membranes of T cells. FASEB J 13: 123-133, 1999.
3. Benten WP, Lieberherr M, Stamm O, Wrehlke C, Guo Z, Wunderlich F. Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol Biol Cell 10: 3113-3123, 1999.
4. Bkaily G, Pothier P, D'Orléans-Juste P, Simaan M, Jacques D, Jaalouk D, Belzile F, Hassan G, Boutin C, Haddad G, Neugebauer W. The use of confocal microscopy in the investigation of cell structure and function in the heart, vascular endothelium and smooth muscle cells. Mol Cell Biochem 172: 171-194, 1997.
5. Cheng J, Alkayed NJ, Hurn PD. Deleterious effects of dihydrotestosterone on cerebral ischemic injury. J Cereb Blood Flow Metab 27: 1553-1562, 2007.
6. Cheng J, Hu W, Toung TJ, Zhang Z, Parker SM, Roselli CE, Hurn PD. Age-dependent effects of testosterone in experimental stroke. J Cereb Blood Flow Metab 29: 486-494, 2008.
7. Cipollone F, Fazia M, Iezzi A, Ciabattoni G, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, De Luca M, Prontera C, Chiarelli F, Cuccurullo F, Mezzetti A. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 24: 1259-1265, 2004.
8. Death AK, McGrath KCY, Sader MA, Nakhla S, Jessup W, Handelsman DJ, Celermajer DS. Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-κB-dependent pathway. Endocrinology 145: 1889-1897, 2004.
9. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur Heart J 21: 890-894, 2000.
10. English KM, Steeds R, Jones TH, Channer KS. Testosterone and coronary heart disease: is there a link? Q J Med 90: 787-791, 1997.
11. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 102: 1906-1911, 2000.
12. Fortunati N, Fissore F, Fazzari A, Becchis M, Comba A, Catalano MG, Berta L, Frairia R. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3′,5′-monophosphate and protein kinase A. Endocrinology 137: 686-692, 1996.
13. George SJ. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. Curr Opin Lipidol 9: 413-423, 1998.
14. Gonzales RJ, Duckles SP, Krause DN. Dihydrotestosterone stimulates cerebrovascular inflammation through NFκB, modulating contractile function. J Cereb Blood Flow Metab 29: 244-253, 2009.
15. González-Cadavid NF, Vernet D, Navarro AF, Rodriguez J, Swerdloff RS, Rajfer J. Up-regulation of the levels of androgen receptor and its mRNA by androgens in smooth-muscle cells from rat penis. Mol Cell Endocrinol 90: 219-229, 1993.
16. Hatakeyama H, Nishizawa M, Nakagawa A, Nakano S, Kigoshi T, Uchida K. Testosterone inhibits tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Lett 530: 129-132, 2002.
17. Hawk T, Zhang YQ, Rajakumar G, Day AL, Simpkins JW. Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats. Brain Res 796: 296-298, 1998.
18. Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16: 2181-2187, 2002.
19. Iadecola C, Gorelick PB. The Janus face of cyclooxygenase-2 in ischemic stroke: shifting toward downstream targets. Stroke 36: 182-185, 2005.
20. Konoplya EF, Popoff EH. Identification of the classical androgen receptor in male rat liver and prostate cell plasma membranes. Int J Biochem 24: 1979-1983, 1992.
21. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 11: 157-162, 1993.
22. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS. Testosterone as a protective factor against atherosclerosis - immunomodulation and influence upon plaque development and stability. J Endocrinol 178: 373-380, 2003.
23. Masferrer JL, Zweifel BS, Colburn SM, Ornberg RL, Salvemini D, Isakson P, Seibert K. The role of cyclooxygenase-2 in inflammation. Am J Ther 2: 607-610, 1995.
24. McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 99: 2317-2322, 1999.
25. Mukherjee TK, Dinh H, Chaudhuri G, Nathan L. Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci USA 99: 4055-4060, 2002.
26. Nakhla AM, Rosner W. Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin. Endocrinology 137: 4126-4129, 1996.
27. Norata GD, Tibolla G, Seccomandi PM, Poletti A, Catapano AL. Dihydrotestosterone decreases tumor necrosis factor-α- and lipopolysaccharide-induced inflammatory response in human endothelial cells. J Clin Endocrinol Metab 91: 546-554, 2006.
28. Padgett DA, Loria RM. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J Neuroimmunol 84: 61-68, 1998.
29. Razmara A, Krause DN, Duckles SP. Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats. Am J Physiol Heart Circ Physiol 289: H1843-H1850, 2005.
30. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453: 807-811, 2008.
31. Saren P, Welgus HG, Kovanen PT. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 157: 4159-4165, 1996.
32. Somjen D, Kohen F, Gayer B, Knoll E, Many A, Stern N. Dihydrotestosterone and estradiol-17β mutually neutralize their inhibitory effects on human vascular smooth muscle cell growth in vitro. J Steroid Biochem Mol Biol 113: 171-176, 2009.
33. Sugimoto K, Iadecola C. Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia. Brain Res 960: 273-276, 2003.
34. Tipping PG, Hancock WW. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques. Am J Pathol 142: 1721-1728, 1993.
35. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol 38: 1654-1661, 2006.
36. Uchida M, Palmateer JM, Herson PS, Devries AC, Cheng J, Hurn PD. Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice. J Cereb Blood Flow Metab 29: 1454-1462, 2009.
37. Warner SJ, Friedman GB, Libby P. Immune interferon inhibits proliferation and induces 2′,5′-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. J Clin Invest 83: 1174-1182, 1989.
38. Williams MR, Ling S, Dawood T, Hashimura K, Dai A, Li H, Liu JP, Funder JW, Sudhir K, Komesaroff PA. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab 87: 176-181, 2002.
39. Writing Group M, Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y, for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2009 Update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-e181, 2009.